Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3616936
Max Phase: Preclinical
Molecular Formula: C51H85N13O9
Molecular Weight: 1024.32
Molecule Type: Small molecule
Associated Items:
ID: ALA3616936
Max Phase: Preclinical
Molecular Formula: C51H85N13O9
Molecular Weight: 1024.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)=CCC/C(C)=C/C(=O)N[C@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O
Standard InChI: InChI=1S/C51H85N13O9/c1-30(2)12-11-13-33(7)28-43(65)57-35(16-21-52)45(67)61-39-20-25-56-44(66)40(26-31(3)4)62-47(69)37(18-23-54)58-46(68)36(17-22-53)60-51(73)42(29-34-14-9-8-10-15-34)64-50(72)41(27-32(5)6)63-48(70)38(19-24-55)59-49(39)71/h8-10,12,14-15,28,31-32,35-42H,11,13,16-27,29,52-55H2,1-7H3,(H,56,66)(H,57,65)(H,58,68)(H,59,71)(H,60,73)(H,61,67)(H,62,69)(H,63,70)(H,64,72)/b33-28+/t35-,36+,37+,38+,39+,40+,41+,42-/m1/s1
Standard InChI Key: KVCNWHBKPDSWGW-IIRXVFBSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1024.32 | Molecular Weight (Monoisotopic): 1023.6593 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. De Zoysa GH, Cameron AJ, Hegde VV, Raghothama S, Sarojini V.. (2015) Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides., 58 (2): [PMID:25495219] [10.1021/jm501084q] |
Source(1):